Japan, Jan. 21 -- AMGEN has got intellectual property rights for 'BISPECIFIC ANTIBODIES WITH CLEAVABLE C-TERMINAL CHARGE-PAIRED TAGS.' Other related details are as follows:
Application Number: JP,2023-191593
Category (FI): C07K16/46,C12N5/10,C12N5/071,C12P21/08,C12N9/48,C12N9/50,C07K14/00,C07K16/00,C12N15/13,C07K7/08
Stage: Grant (IP right document published.)
Filing Date: Nov. 9, 2023
Publication Date: Feb. 21, 2024
The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100
Disclaimer: Curated by HT Syndication.
